母婴ABO不兼容性对新生儿的影响:在中国人口中进行的一组研究
Yuanjun Wu1,2,3, Ganping Guo4,2, Yinglin Wu4,2
1Department of Transfusion Medicine, Dongguan Maternal and Child Health Hospital, Dongguan, Guangdong, China wuyuanjun199@126.com.
Archives of disease in childhood. Fetal and neonatal edition
|October 15, 2025
概括
母婴ABO不相容性显著增加新生儿住院治疗,新生儿高 bilirubinaemia (NHB) 和贫血. 这种情况往往导致新生儿严重的血液溶解性疾病 (HDN),挑战传统观点.
科学领域:
- 新生儿医学 新生儿医学
- 免疫学 免疫学 免疫学
- 儿科 儿科 儿科
背景情况:
- 传统观点:母婴ABO不相容性只会导致新生儿轻度血解性疾病 (HDN).
- 临床观察表明结果比传统认为的更严重.
- 缺乏大规模人口数据来验证对新生儿的影响.
研究的目的:
- 研究母婴ABO不相容性对新生儿健康结果的影响.
- 分析住院率,新生儿高 bilirubinaemia (NHB),和贫血的发生率.
- 确定ABO-不兼容的HDN (ABO-HDN) 对NHB和新生儿贫血的贡献.
主要方法:
- 对47679名中国新生儿的住院和NHB和贫血发病率的分析.
- 在不同O-B和O-A母婴ABO不兼容性中比较ABO-HDN发生率.
- 评估ABO-HDN在NHB和新生儿贫血中的病因作用.
主要成果:
- 患有ABO不相容的新生儿显示出更高的住院,NHB和贫血率.
- 风险等级:O-B > O-A > 非O-A/O-B 不兼容性.
- 在不相容的新生儿中,ABO-HDN是NHB (41.11%) 和贫血 (42.34%) 的重要因素.
结论:
- 母婴ABO不相容性经常导致严重的HDN.
- 它是NHB和新生儿贫血的主要原因.
- 显著增加的新生儿住院率与 ABO 不相容性有关.
相关概念视频
Development of Immunocompetence
789
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
789
Rh Blood Group
2.7K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
2.7K
The ABO Blood Group
4.6K
The ABO blood group system is a critical element of transfusion medicine, essential for determining blood compatibility in transfusions and organ transplants. It is based on specific antigens, or agglutinogens, present on the surface of red blood cells (RBCs) and corresponding antibodies, or agglutinins, in the blood plasma.
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...
4.6K
Blood Transfusion
2.1K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.1K
Teratogenicity
4.0K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.0K


